STEVEN PRESTRELSKI

Business address
C/O Xeris Pharmaceuticals, 180 N. Lasalle Street, Suite 1800, Chicago, IL, 60601
Top holdings (ownership)
XERS
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
STEVEN PRESTRELSKI has filed 22 SEC EDGAR filings since 20 Jun 2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 01 Feb 2023 31 Jan 2023 001-40880
4 Open Document Open Filing FORM 4 24 Feb 2022 22 Feb 2022 001-40880
4 Open Document Open Filing FORM 4 05 Jan 2022 03 Jan 2022 001-40880
4 Open Document Open Filing FORM 4 SUBMISSION 05 Oct 2021 05 Oct 2021 001-40880
4 Open Document Open Filing FORM 4 SUBMISSION 05 Oct 2021 05 Oct 2021 001-38536
3 Open Document Open Filing FORM 3 05 Oct 2021 05 Oct 2021 001-40880
4 Open Document Open Filing FORM 4 13 Apr 2021 12 Apr 2021 001-38536
4 Open Document Open Filing FORM 4 01 Feb 2021 29 Jan 2021 001-38536
4 Open Document Open Filing FORM 4 15 Jan 2021 13 Jan 2021 001-38536
4 Open Document Open Filing FORM 4 12 Jan 2021 11 Jan 2021 001-38536
4 Open Document Open Filing FORM 4 17 Dec 2020 16 Dec 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 17 Aug 2020 14 Aug 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 02 Mar 2020 31 Jan 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 14 Jan 2020 13 Jan 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 20 Nov 2019 19 Nov 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 16 Oct 2019 14 Jan 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 12 Apr 2019 11 Apr 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 01 Feb 2019 31 Jan 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 15 Jan 2019 11 Jan 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 02 Jan 2019 24 Dec 2018 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 27 Jun 2018 25 Jun 2018 001-38536
3 Open Document Open Filing FORM 3 SUBMISSION 20 Jun 2018 20 Jun 2018 001-38536